MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1513/annalsats.202410-1020oc

Медицинская библиотека · Annals of the American Thoracic Society · 2025

Association between Difficulty Affording Medications and Outcomes in Chronic Obstructive Pulmonary Disease.

Mallya Sonal G, Upadhyay Alka, Psoter Kevin J, Case Meredith A, Vest Michael T, Putcha Nirupama, Hansel Nadia N, Eakin Michelle N

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

Rationale: Medications, including inhaled bronchodilators, are essential for effective management of chronic obstructive pulmonary disease (COPD) and to improve clinical outcomes. However, medications are a major driver of out-of-pocket costs for individuals with COPD. The impact of cost of medications on clinical outcomes in COPD has not been studied.

Objectives

To examine the association between difficulty affording medications and COPD morbidity, psychological well-being, and medication adherence.

Methods

Individuals with a physician's diagnosis of COPD who were prescribed at least one daily maintenance medication were recruited from centers in the Mid-Atlantic area and followed for 12 months as part of the Medication Adherence Research in COPD (MARC) cohort. Patient-reported COPD outcomes, measures of psychological well-being, exacerbation data, and difficulty affording medications were assessed at 6-month intervals. Medication adherence was measured during the 12-month period using electronic monitors. The association between difficulty affording medications at baseline and outcomes at 12 months was evaluated using multivariable regression models. A fixed effects regression model was conducted to evaluate how changes in difficulty affording medications are associated with outcomes over time.

Results

Of the 249 participants with completed baseline assessments, a total of 44 (18%) participants reported delaying refilling medications because of cost at baseline. Over the course of the 12-month period, 68 (27%) participants reported delaying refilling medications at any time point because of cost. After adjusting for baseline covariates, no associations between difficulty affording medications at baseline and outcomes at 12 months were observed. In the fixed effects model, changes in difficulty affording medications were associated with worse COPD health status, dyspnea, and health-related quality of life; increased symptoms of anxiety and depression; and lower objectively measured medication adherence but not occurrence of exacerbations.

Conclusions

In this multicenter cohort of individuals with physician-diagnosed COPD, we found an association between changes in self-reported difficulty affording medications and increased patient-reported respiratory morbidity, increased anxiety and depression symptoms, and decreased objectively measured medication adherence over time, but no association with exacerbations. These findings suggest that cost of COPD-specific treatments is an important and potentially modifiable social determinant of health for individuals with COPD.

Для цитирования: Mallya Sonal G, Upadhyay Alka, Psoter Kevin J, Case Meredith A, Vest Michael T, Putcha Nirupama, Hansel Nadia N, Eakin Michelle N. Association between Difficulty Affording Medications and Outcomes in Chronic Obstructive Pulmonary Disease.. Annals of the American Thoracic Society. 2025. DOI: 10.1513/annalsats.202410-1020oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.